Investigating biomarkers of Staphylococcus aureus bacteremia in patients - School of Pharmacy
Por um escritor misterioso
Descrição
The Centers for Disease Control identifies methicillin-resistant S. aureus (MRSA) as a serious health threat with greater than 100,000 invasive infections and 20,000 patient deaths annually in the United States. Despite recent advancements in available treatment options for methicillin-sensitive S.
Methicillin-resistant Staphylococcus aureus: novel treatment approach breakthroughs, Bulletin of the National Research Centre
Phenotyping of Methicillin-Resistant Staphylococcus aureus Using a Ratiometric Sensor Array
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Frontiers Management of Staphylococcus aureus Bloodstream Infections
IJMS, Free Full-Text
Staphylococcus aureus Bacteremia in Adults
PDF) Select controversies in the management of methicillin-resistant Staphylococcus aureus bacteremia: answers and remaining questions from recent evidence
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study - The Lancet Infectious Diseases
Infectious Disease Special Edition - Summer 2021 by McMahon Group - Issuu
Bloodstream infections in critically ill patients: an expert statement
The Golden Grapes of Wrath – Staphylococcus aureus Bacteremia: A Clinical Review - The American Journal of Medicine
PDF) Select controversies in the management of methicillin-resistant Staphylococcus aureus bacteremia: answers and remaining questions from recent evidence
